Rivastigmine Transdermal System
NDC 63629-2065, Rivastigmine, patch, extended release, from Bryant Ranch Prepack.
- Product NDC
- 63629-2065
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63629-2065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE4.6 mg/24h
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63629-2065-1 | 63629206501 | 30 POUCH in 1 CARTON (63629-2065-1) / 1 PATCH in 1 POUCH (63629-2065-2) / 24 h in 1 PATCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/82630f84-fb47-47ab-8ee2-1720a486de02
Use it
Look up 63629-2065 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63629-2065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63629-2065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.